UCB - Net Income

Stock Price
266.50
Daily Change
5.50 2.11%
Monthly
13.45%
Yearly
42.59%
Q1 Forecast
249.19

UCB reported EUR857M in Net Income for its fiscal semester ending in December of 2024.





Net Income Change Date
Alcon AG USD 237M 61M Sep/2025
Almirall EUR 26.58M 31.82M Jun/2025
Amarin USD -7.74M 6.4M Sep/2025
argenx SE USD 344.26M 98.9M Sep/2025
AstraZeneca USD 2.53B 83M Sep/2025
Bayer EUR -963M 764M Sep/2025
Galapagos EUR -202.11M 96.36M Sep/2025
Genmab DKK 336M 141M Jun/2025
GlaxoSmithKline GBP 2.01B 570M Sep/2025
GRIFOLS EUR 126.96M 9.9M Sep/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Lonza CHF 307M 22M Dec/2024
Merck EUR 902M 250M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Orion EUR 96M 13.5M Sep/2025
Recordati EUR 110.16M 19.08M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
UCB EUR 857M 649M Dec/2024
Unibail Rodamco EUR 655.7M 581.2M Jun/2025